Andrew C Adams Selected Research

fibroblast growth factor 21

1/2022	FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes.
1/2020	Whole-body and adipose tissue-specific mechanisms underlying the metabolic effects of fibroblast growth factor 21 in the Siberian hamster.
1/2020	A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive β-Cell Hyperplasia.
1/2020	Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity.
1/2018	Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21-Dependent Mechanism.
11/2017	Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury.
10/2017	FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans.
1/2017	Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster.
11/2016	FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency.
8/2016	Fibroblast growth factor 21 has no direct role in regulating fertility in female mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew C Adams Research Topics

Disease

13	Obesity 01/2020 - 11/2009
8	Insulin Resistance 01/2022 - 05/2013
8	COVID-19 01/2022 - 10/2020
8	Body Weight (Weight, Body) 01/2020 - 01/2012
5	Weight Loss (Weight Reduction) 01/2020 - 11/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2015
3	Infections 10/2021 - 01/2021
3	Glucose Intolerance 01/2020 - 02/2014
3	Hyperglycemia 10/2017 - 02/2014
3	Dyslipidemias (Dyslipidemia) 06/2015 - 01/2012
2	Disease Progression 10/2021 - 01/2013
2	Non-alcoholic Fatty Liver Disease 11/2017 - 05/2010
2	Hyperinsulinism (Hyperinsulinemia) 10/2017 - 06/2015
2	Weight Gain 04/2016 - 04/2011
2	Metabolic Diseases (Metabolic Disease) 04/2016 - 01/2013
2	Fatty Liver 01/2015 - 02/2014
2	Neoplasms (Cancer) 01/2014 - 09/2012
1	Immediate Hypersensitivity 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Hypertriglyceridemia 01/2018
1	Fibrosis (Cirrhosis) 11/2017
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 11/2017
1	Binge Drinking 11/2017
1	Starvation 08/2016
1	Infertility (Sterility) 08/2016
1	Inflammation (Inflammations) 01/2016
1	Hyperplasia 01/2016
1	Anorexia Nervosa 10/2015
1	Diabetes Mellitus 06/2014
1	Breast Neoplasms (Breast Cancer) 09/2012
1	Anosmia 01/2011

Drug/Important Bio-Agent (IBA)

22	fibroblast growth factor 21IBA 01/2022 - 05/2010
9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2009
7	bamlanivimabIBA 01/2022 - 10/2020
7	Insulin (Novolin)FDA Link 10/2017 - 11/2009
6	LipidsIBA 12/2019 - 11/2009
4	CarbohydratesIBA 01/2022 - 11/2009
4	Neutralizing AntibodiesIBA 12/2021 - 10/2020
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2012
3	etesevimabIBA 01/2022 - 01/2021
3	bamlanivimab and etesevimab drug combinationIBA 01/2022 - 01/2021
3	Monoclonal AntibodiesIBA 10/2021 - 01/2021
3	AdiponectinIBA 01/2020 - 05/2013
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 09/2012
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2013
2	AntigensIBA 12/2021 - 10/2020
2	CholesterolIBA 04/2016 - 01/2013
1	Pioglitazone (Actos)FDA Link 01/2022
1	Exenatide (Byetta)FDA Link 01/2022
1	VaccinesIBA 10/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 12/2019
1	Cholic AcidIBA 01/2018
1	EstersIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Ethanol (Ethyl Alcohol)IBA 11/2017
1	Protein Isoforms (Isoforms)IBA 10/2017
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2017
1	GonadotropinsIBA 08/2016
1	Nonesterified Fatty Acids (NEFA)IBA 04/2016
1	Antipsychotic Agents (Antipsychotics)IBA 10/2015
1	Olanzapine (Zyprexa)FDA Link 10/2015
1	naringeninIBA 06/2015
1	FlavonoidsIBA 06/2015
1	Promyelocytic Leukemia ProteinIBA 01/2015
1	Hormones (Hormone)IBA 02/2014
1	Sirtuin 1IBA 02/2014
1	Blood Glucose (Blood Sugar)IBA 05/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2012
1	Agouti-Related ProteinIBA 04/2011
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2011
1	LeptinIBA 11/2009

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2013
2	Intravenous Infusions 10/2021 - 01/2021
1	Glycemic Control 12/2019
1	Ketogenic Diet 11/2009